SCHEMBL374791

SCHEMBL374791

c1nc2cnnnc2s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14437972 0.67 ALDH1A1 (0.31)
SCHEMBL374646 0.65
SCHEMBL31049795 0.64
SCHEMBL209182 0.64
SCHEMBL31433404 0.64
SCHEMBL21477589 0.63 ALDH1A1 (0.32)
SCHEMBL240497 0.62
SCHEMBL860168 0.62 KDM4E (0.32)
SCHEMBL21955969 0.62 ALDH1A1 (0.31)
SCHEMBL969038 0.62 PIK3CD (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250072277-A1 LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-02-27 US claimed
CN-119521943-A Light emitting element and display device including the same 三星显示有限公司 2025-02-25 CN claimed
US-20240246959-A1 BENZIMIDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2024-07-25 US claimed
EP-4242202-A1 BENZIMIDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) 2023-09-13 EP claimed
US-8314109-B2 6-heterocyclic-imidazo[1,2-α]pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof SANOFI (FR) 2012-11-20 US claimed
US-20100317675-A1 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-12-16 US claimed
EP-2225240-A2 DERIVATIVES OF 6-HETEROCYCLIC-IMIDAZOÝL,2-A¨PYRROINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF Sanofi-Aventis (FR) 2010-09-08 EP claimed
WO-2009106750-A2 DERIVATIVES OF 6-HETEROCYCLIC-IMIDAZO[L,2-A]PYRROINE-2-CARBOXAMIDES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF SANOFI-AVENTIS (FR) 2009-09-03 WO claimed
US-4447604-A ANTICANCER AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1984-05-08 US claimed
US-20260013395-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE INCLUDING THE DISPLAY DEVICE SAMSUNG DISPLAY CO LTD (KR) 2026-01-08 US disclosed
US-20250133938-A1 DISPLAY DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2025-04-24 US disclosed
US-20250072277-A1 LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-02-27 US disclosed
US-20250072277-A1 LIGHT EMITTING ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-02-27 US disclosed
US-20240246959-A1 BENZIMIDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2024-07-25 US disclosed
WO-2006101217-A2 LUMINOUS COMPOUND CONTAINING LANTHANIDE ION FUJIFILM CORPORATION (JP) 2006-09-28 WO disclosed
US-4447604-A ANTICANCER AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1984-05-08 US disclosed
US-4447604-A ANTICANCER AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1984-05-08 US disclosed
US-4447604-A ANTICANCER AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1984-05-08 US disclosed
US-4127660-A ANTIULCER JOHN WYETH & BROTHER LIMITED (GB) 1978-11-28 US disclosed
US-4127660-A ANTIULCER JOHN WYETH & BROTHER LIMITED (GB) 1978-11-28 US disclosed